PETALING JAYA: Hovid Bhd’s gearing will improve after the disposal of its 51% interest in India-based Biodeal Pharmaceuticals Pte Ltd (BPPL) for 102 million Indian rupees or RM5.56mil.
It said BPPL’s liabilities, which included unsecured loans of RM5.79mil as at June 30, 2013 (FY13), would no longer be included in the group’s financial results going forward.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
